Veronica Allen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Veronica Allen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Mark Patrick Nicol
Marshall Centre, Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia
3 shared publications Faye Black
Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa
2 shared publications- Heather Jessica Zar
Department of Pediatrics and Child Health, Red Cross War Memorial Children’s Hospital, University of Cape Town, Cape Town, South Africa
2 shared publications Jacinta Munro
Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa
2 shared publicationsLesley Workman
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
2 shared publicationsWashiefa Isaacs
Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa
2 shared publications
Latest Publications
- Open Access
- 17 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Investigating the population structure of Moraxella catarrhalis using a cgMLST scheme and LIN code system
Moraxella catarrhalis is an important cause of infectious exacerbations of chronic obstructive pulmonary disease and otitis media. To investigate the population structure of M. catarrhalis, we developed a core-genome multilocus sequence typing (cgMLST) scheme using 1319 core genes, and a life identification number (LIN) barcode classification system. Whole-genome analyses of nearly 2000 genomes confirmed divergent seroresistant (SR) and serosensitive (SS) M. catarrhalis lineages with distinct evolutionary trajectories. SR genomes are more conserved, while SS genomes exhibited greater genetic variability. Virulence gene analyses revealed lineage-specific variations in ubiquitous surface proteins (UspA1 and UspA2) and lipooligosaccharide (LOS) types. The bro β-lactamase, and mcb bacteriocin cluster, are more common in SR lineages, which suggested different selective pressures and adaptation. Here, we show that this cgMLST scheme and LIN code system provide a robust method for characterising M. catarrhalis, distinguish between SR and SS lineages, and offer a unified framework for population structure analyses.
- 17 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessInvestigating the population structure of Moraxella catarrhalis using a cgMLST scheme and LIN code system
Moraxella catarrhalis is an important cause of infectious exacerbations of chronic obstructive pulmonary disease and otitis media. To investigate the population structure of M. catarrhalis, we developed a core-genome multilocus sequence typing (cgMLST) scheme using 1319 core genes, and a life identification number (LIN) barcode classification system. Whole-genome analyses of nearly 2000 genomes confirmed divergent seroresistant (SR) and serosensitive (SS) M. catarrhalis lineages with distinct evolutionary trajectories. SR genomes are more conserved, while SS genomes exhibited greater genetic variability. Virulence gene analyses revealed lineage-specific variations in ubiquitous surface proteins (UspA1 and UspA2) and lipooligosaccharide (LOS) types. The bro β-lactamase, and mcb bacteriocin cluster, are more common in SR lineages, which suggested different selective pressures and adaptation. Here, we show that this cgMLST scheme and LIN code system provide a robust method for characterising M. catarrhalis, distinguish between SR and SS lineages, and offer a unified framework for population structure analyses.
- Open Access
- 1 May 2014
- Published by Elsevier in The Lancet Global Health
- Vol. 2 (5) , e278-e284
Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study
- 1 May 2014
- Published by Elsevier in The Lancet Global Health
- Vol. 2 (5) , e278-e284
Open AccessUrine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study
- Open Access
- 2 July 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 55 (8) , 1088-1095
Rapid Molecular Diagnosis of Pulmonary Tuberculosis in Children Using Nasopharyngeal Specimens
Background. A rapid diagnosis of pediatric pulmonary tuberculosis (PTB) using Xpert MTB/RIF (Mycobacterium tuberculosis/rifampicin) automated testing on induced sputum (IS) is possible, but the capacity for performing IS is limited. The diagnosis using a nasopharyngeal aspirate (NPA), which can be non-invasively obtained, is desirable. Methods. Paired specimens (NPA and IS) were tested using smear, liquid culture and Xpert. The diagnostic accuracy of Xpert and smear was compared with culture for different specimens in children with suspected PTB. Results. There were 535 children [median age 19 months, 117 (21·9%) HIV-infected] who had one IS and one NPA specimen; 396 had two paired specimens. A positive smear, Xpert test or culture occurred in 30 (5.6%), 81 (15.1%) and 87 children (16.3%), respectively. The culture yield was higher from IS (84/87, 96.6%) vs NPA (61/87, 70.1%, P < .001). Amongst children with two paired specimens, 63 culture-confirmed cases occurred [60 (95.2%) IS vs 48 (76.2%) NPA, P = .002]. The sensitivity of two Xpert tests was similar for IS and NPAs [(45/63) 71% vs (41/63) 65%, P = .444)]; the sensitivity of smear was lower for IS (21/63, 33%) and NPA (16/63, 25%). The incremental yield from a second IS was 9 cases (17.6%) by culture and 9 (25%) by Xpert testing; a second NPA increased the culture yield by 10 (26.3%) and Xpert by 11 (36.7%). Xpert specificity was 99.1% (98.1–100) for IS and 98.2% (96.8–99.6) for NPAs. Xpert testing provided faster results than culture (median 0 vs 15 days, P < .001). Conclusions. Xpert testing on 2 NPAs is useful in children with suspected PTB, particularly in settings where IS and culture are not feasible.
- 2 July 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 55 (8) , 1088-1095
Open AccessRapid Molecular Diagnosis of Pulmonary Tuberculosis in Children Using Nasopharyngeal Specimens
Background. A rapid diagnosis of pediatric pulmonary tuberculosis (PTB) using Xpert MTB/RIF (Mycobacterium tuberculosis/rifampicin) automated testing on induced sputum (IS) is possible, but the capacity for performing IS is limited. The diagnosis using a nasopharyngeal aspirate (NPA), which can be non-invasively obtained, is desirable. Methods. Paired specimens (NPA and IS) were tested using smear, liquid culture and Xpert. The diagnostic accuracy of Xpert and smear was compared with culture for different specimens in children with suspected PTB. Results. There were 535 children [median age 19 months, 117 (21·9%) HIV-infected] who had one IS and one NPA specimen; 396 had two paired specimens. A positive smear, Xpert test or culture occurred in 30 (5.6%), 81 (15.1%) and 87 children (16.3%), respectively. The culture yield was higher from IS (84/87, 96.6%) vs NPA (61/87, 70.1%, P < .001). Amongst children with two paired specimens, 63 culture-confirmed cases occurred [60 (95.2%) IS vs 48 (76.2%) NPA, P = .002]. The sensitivity of two Xpert tests was similar for IS and NPAs [(45/63) 71% vs (41/63) 65%, P = .444)]; the sensitivity of smear was lower for IS (21/63, 33%) and NPA (16/63, 25%). The incremental yield from a second IS was 9 cases (17.6%) by culture and 9 (25%) by Xpert testing; a second NPA increased the culture yield by 10 (26.3%) and Xpert by 11 (36.7%). Xpert specificity was 99.1% (98.1–100) for IS and 98.2% (96.8–99.6) for NPAs. Xpert testing provided faster results than culture (median 0 vs 15 days, P < .001). Conclusions. Xpert testing on 2 NPAs is useful in children with suspected PTB, particularly in settings where IS and culture are not feasible.